Research and development is a necessary, though often costly, component of manufacturing. Utilizing the R&D Credit can help offset those costs.

Following are six reasons why pharmaceutical and life sciences companies must prioritize track-and-trace technology in their logistics operations in 2025.

The long-promised tariffs scheduled to take effect March 4 would easily be among the most sweeping of the Trump era, applying to roughly $1.5 trillion in annual imports.

Adding FTZ or bonded warehousing capabilities can have a huge impact for 3PL providers, particularly in areas with high volumes of international trade.

U.S.-based companies are also likely to suffer because of reciprocal tariffs imposed by America’s trading partners in retaliation, threatening profit from exports. 

Prices will rise, maybe wages will too. The question is whether Trump’s new tariff regime will pay off. 

Shippers with complex needs and tight budgets are outsourcing more of their freight to managed transportation providers.

The bloc could move quickly by re-applying duties it first imposed on the U.S. during Trump’s first term. 

Join us for an exclusive conversation with Scott DeGroot, former VP of Global Planning at Kimberly-Clark (Now with the University of Tennessee), as he shares how he got support for innovative supply chain strategies to drive cost savings, improve efficiency, and enable reinvestment in advanced systems.

Can the U.S. pharmaceutical supply chain come home — or, at least, get closer to it?